These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 7022795)
21. In vitro effect of methylprednisolone on protein synthesis of activated canine thymus-derived lymphocytes. Rosenberg JC; Colburn WA; Brennan P; Lysz K; Palutke M; Stubbs SS; Rosenberg SA Transplant Proc; 1975 Dec; 7(4):547-56. PubMed ID: 128165 [TBL] [Abstract][Full Text] [Related]
22. Modification of kidney graft survival in dog and man by pre-operative transfusion to the donor. Jeekel J; Van der Linden CJ; Vegt PA; Buurman WA; Harder F; Persijn G Proc Eur Dial Transplant Assoc; 1980; 17():457-61. PubMed ID: 7017690 [TBL] [Abstract][Full Text] [Related]
23. In vitro monitoring of cadaver kidney donor pretreatment by lymphocyte culture. Jeffery JR; Guttmann RD; Charpentier B Clin Exp Immunol; 1976 Sep; 25(3):437-41. PubMed ID: 134860 [TBL] [Abstract][Full Text] [Related]
25. HLA-DR matched transfusions: development of donor-specific T- and B-cell antibodies and renal allograft outcome. Christiaans MH; van Hooff JP; Nieman F; van den Berg-Loonen EM Transplantation; 1999 Apr; 67(7):1029-35. PubMed ID: 10221489 [TBL] [Abstract][Full Text] [Related]
26. Combined effect of recipient blood transfusion and donor pretreatment with cyclophosphamide and methylprednisolone. Corry RJ; West JC Transplant Proc; 1981 Mar; 13(1 Pt 1):161-3. PubMed ID: 7022814 [No Abstract] [Full Text] [Related]
27. The enhancing effect of donor pretreatment and low dose immunosuppression in dogs. Swistel AJ; McCabe RE; Lorieo DR; Wildstein A; Pierce JC; Fitzpatrick HF Proc Clin Dial Transplant Forum; 1978 Nov 18-20; 8():93-5. PubMed ID: 386328 [No Abstract] [Full Text] [Related]
28. Donor pretreatment with cyclophosphamide and methylprednisolone. Brom HL; van Breda Vriesman PJ Transplantation; 1983 Jul; 36(1):106-7. PubMed ID: 6408773 [No Abstract] [Full Text] [Related]
29. Effects of FTY720 on peripheral blood lymphocytes and graft infiltrating cells in a rat model of chronic renal allograft rejection. Koch M; Poehnert D; Nashan B Transpl Immunol; 2016 Mar; 35():12-7. PubMed ID: 26802360 [TBL] [Abstract][Full Text] [Related]
30. Donor pretreatment on perfused cadaver kidneys: experimental observations. Sy G; Taiyebb S; Toledo-Pereyra LH Am Surg; 1981 Jul; 47(7):307-8. PubMed ID: 7020513 [No Abstract] [Full Text] [Related]
37. The in vivo cytotoxic activity of procarbazine and procarbazine metabolites against L1210 ascites leukemia cells in CDF1 mice and the effects of pretreatment with procarbazine, phenobarbital, diphenylhydantoin, and methylprednisolone upon in vivo procarbazine activity. Shiba DA; Weinkam RJ Cancer Chemother Pharmacol; 1983; 11(2):124-9. PubMed ID: 6627598 [TBL] [Abstract][Full Text] [Related]
38. Cadaver Kidney transplantation. Effect of hypotension and donor pretreatment with methylprednisolone and phenoxybenzamine. Toledo-Pereyra LH; Simmons RL; Olson LC; Najarian JS Minn Med; 1979 Mar; 62(3):159-61. PubMed ID: 370540 [No Abstract] [Full Text] [Related]
39. Prolongation of kidney allograft survival in dogs with donor pretreatment. Chassot PG; Beaudoin JG; Guttmann RD Surg Forum; 1974; 25(0):314-6. PubMed ID: 4612787 [No Abstract] [Full Text] [Related]
40. Characteristics and function of suppressor T lymphocytes in immunologically unresponsive rats following pretreatment with UV-B-irradiated donor leukocytes and peritransplant cyclosporine. Oluwole SF; Reemtsma K; Hardy MA Transplantation; 1989 Jun; 47(6):1001-7. PubMed ID: 2525288 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]